BIOMAT Database Logo BIOMAT Database Logo

[Determination of sensitivity to cytostatic preparations during chemotherapy of malignant tumors]. 1977

G K Stepankovskaia, and A I Milianovskiĭ, and G D Frolova

UI MeSH Term Description Entries
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000477 Alkylating Agents Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. Alkylating Agent,Alkylator,Alkylators,Agent, Alkylating,Agents, Alkylating

Related Publications

G K Stepankovskaia, and A I Milianovskiĭ, and G D Frolova
[Individualization of chemotherapy through in vitro predictive determination of the cytostatic sensitivity of malignant tumors].
October 1989, Deutsche medizinische Wochenschrift (1946),
G K Stepankovskaia, and A I Milianovskiĭ, and G D Frolova
[Sensitivity tests of human malignant tumors to cytostatic drugs].
February 1971, Klinische Wochenschrift,
G K Stepankovskaia, and A I Milianovskiĭ, and G D Frolova
[Cytostatic chemotherapy in the treatment of malignant tumors].
August 1966, Arztliche Forschung,
G K Stepankovskaia, and A I Milianovskiĭ, and G D Frolova
[Cytostatic chemotherapy of malignant tumors from the viewpoint of gynecology].
July 1963, Die Medizinische Welt,
G K Stepankovskaia, and A I Milianovskiĭ, and G D Frolova
[Sensitivity testing of malignant human tumors against cytostatic agents. II].
February 1972, Klinische Wochenschrift,
G K Stepankovskaia, and A I Milianovskiĭ, and G D Frolova
[Regional cytostatic chemotherapy of malignant tumors in the orofacial area].
June 1968, Deutsche zahnarztliche Zeitschrift,
G K Stepankovskaia, and A I Milianovskiĭ, and G D Frolova
[Cytostatic drugs and malignant tumors; a new aspect of chemotherapy].
June 1958, La Presse medicale,
G K Stepankovskaia, and A I Milianovskiĭ, and G D Frolova
Resistance in malignant tumors: can resistance assays optimize cytostatic chemotherapy?
January 2008, Pharmacology,
G K Stepankovskaia, and A I Milianovskiĭ, and G D Frolova
[In vitro-determination of the cytostatic sensitivity of malignant tumours (author's transl)].
October 1973, Archiv fur klinische und experimentelle Ohren- Nasen- und Kehlkopfheilkunde,
G K Stepankovskaia, and A I Milianovskiĭ, and G D Frolova
[New formation of malignant tumors during cytostatic therapy. Case report].
September 1971, Strahlentherapie,
Copied contents to your clipboard!